A Combination of Two Receptor Tyrosine Kinase Inhibitors, Canertinib and PHA665752 Compromises Ovarian Cancer Cell Growth in 3D Cell Models

Overview of attention for article published in Oncology and Therapy, September 2016

Altmetric Badge

Mentioned by

So far, Altmetric has seen 2 X posts from 1 X users, with an upper bound of 1,191 followers.

Two receptor tyrosine kinase inhibitors compromise #ovariancancer cell growth. Click the link to read more https://t.co/CIiS8lHZlU #Oncology https://t.co/7uOHGheDn8

Two receptor tyrosine kinase inhibitors compromise #ovariancancer cell growth in this recent study: https://t.co/CIiS8lHZlU #Oncology

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.